Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Borylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104114563A reveals selective borylation for organic semiconductors. Enhance supply chain reliability and reduce manufacturing costs with high-purity intermediates.
Patent CN110407863A reveals a zirconium-catalyzed transfer borylation route. This method offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Novel silver-catalyzed method for alkyl borate esters ensures high purity and supply chain stability for pharmaceutical intermediates manufacturing globally.
Novel copper-catalyzed synthesis using acetylene enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Patent CN114685549B reveals novel synthesis for high-purity OLED materials. Achieve cost reduction in electronic chemical manufacturing with scalable boron nitrogen technology.
Patent CN109575063B details a mild, metal-free borylation method using alkoxides. This breakthrough offers cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN103570754B offers a cost-effective route for Linifanib intermediates. High yield, scalable process for pharmaceutical supply chains ensuring reliable global sourcing.
Novel ruthenium catalysis for methyl ester selective dehydroboration. Offers significant cost reduction and supply chain reliability for high purity pharmaceutical intermediates manufacturing.
Patent CN112979434A reveals a novel Suzuki coupling route for high-purity discotic liquid crystals, offering significant cost reduction in display material manufacturing.
Patent CN112442060A details a mild copper-catalyzed borylation method using N,O-aminals, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101155801A details a Pd-catalyzed borylation route for high-purity indole intermediates, offering significant cost reduction in pharmaceutical manufacturing and scalable supply chain solutions.
Patent CN102125875A details a novel ferrocenyl-palladium catalyst for one-pot biaryl synthesis, offering high yields and streamlined manufacturing for pharmaceutical intermediates.
Novel copper-catalyzed borylation cyclization for agrochemical intermediates. High atom economy, scalable process, and reduced environmental impact for pheromone synthesis.
Patent CN104114563B reveals selective borylation for organic semiconductors. Enhances supply chain reliability and reduces manufacturing costs for high-purity electronic materials.
Novel 3-step synthesis from 2-naphthol for OLED intermediates. High yield, low cost route. Reliable supply chain partner for display materials.
Patent CN106146543A details efficient Rh-catalyzed synthesis of chiral alpha-amino tertiary borates, offering cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Discover a cost-effective, safe process for synthesizing N-substituted piperidine-4-boronic acid intermediates, eliminating expensive palladium catalysts.
Patent CN112174993A details a one-pot Pd-catalyzed route for 2,6-dimethylpyridine-3-boric acid, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel one-pot synthesis avoids cryogenic conditions. High purity boron intermediates for Suzuki coupling. Cost-effective scalable manufacturing solution.
Patent CN110885341B reveals a transition-metal-free borylation method using alkyl bromides. This breakthrough offers cost reduction in fine chemical manufacturing and high-purity alkyl boronic esters.